本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Rocket Pharmaceuticals, Inc.

3.41
-0.0200-0.58%
盤前3.630.2200+6.45%08:30 EDT
成交量:366.10萬
成交額:1,231.23萬
市值:3.74億
市盈率:-20.06
高:3.69
開:3.65
低:3.21
收:3.43
52周最高:5.45
52周最低:2.53
股本:1.10億
流通股本:8,496.03萬
量比:3.18
換手率:4.31%
股息:- -
股息率:- -
每股收益(TTM):-0.1700
每股收益(LYR):-2.0100
淨資產收益率:-4.77%
總資產收益率:-28.42%
市淨率:1.01
市盈率(LYR):-1.70

資料載入中...

2026/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/15

重要事件披露

Form 8-K - Current report
2026/09/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/02

交易所摘牌聲明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2026/08/28

重要事件披露

Form 8-K - Current report
2026/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/11

重要事件披露

Form 8-K - Current report
2026/08/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/03

重要事件披露

Form 8-K - Current report
2026/07/31

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/15

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/07/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities